Pharmaceutical franchising, product distribution, and medicinal services in India.
Annual revenue $2.0M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Aster Medipharm

Aster Medipharm is a company. Aster Medipharm offers products and services including Cardiac and Diabetic Products and Analgesic and Antiulcerants.

  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Aster Medipharm Pvt Ltd
  • Jurisdiction Jaipur, Rajasthan, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.96 M (USD)
    20.14
    as on Mar 31, 2023
  • Net Profit
    $31.48 K (USD)
    254.99
    as on Mar 31, 2023
  • EBITDA
    $160.68 K (USD)
    28.09
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aster Medipharm

Aster Medipharm offers a comprehensive portfolio of products and services, including Cardiac and Diabetic Products and Analgesic and Antiulcerants.

Product name locked
Category locked
Primary

Cardiac and diabetic products are manufactured and distributed for the treatment of related health issues, focusing on effective relief for patients

Product name locked
Category locked
Locked

Analgesic and antiulcerants are provided as part of a broader range to address pain and digestive conditions, supporting general healthcare needs

Funding Insights of Aster Medipharm

Premium access

Detailed funding history for Aster Medipharm

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aster Medipharm

Investments
Premium access

Investment portfolio details for Aster Medipharm

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Aster Medipharm

Premium access

Detailed financials for Aster Medipharm

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aster Medipharm Comparisons

Aster Medipharm Primary company
Description
Pharmaceutical franchising, product distribution, and medici...
Location
-
Founded Year
-
Annual Revenue
$1.96 M (USD)
Net Profit
$31.48 K (USD)
EBITDA
$160.68 K (USD)
Employees
Not available
Premium access

Peer comparison for Aster Medipharm

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aster Medipharm

Premium access

Detailed competitors of Aster Medipharm

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aster Medipharm

Premium access

Complete news archive for Aster Medipharm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aster Medipharm

Annual revenue of Aster Medipharm is $1.96M as on Mar 31, 2023.

Aster Medipharm is recognized as a prominent PCD pharma company in India, where high-quality pharmaceutical products are manufactured and distributed through a franchise model. Products are developed with a focus on efficiency, dedication, and adherence to ISO 9001:2015 and WHO-GMP standards, ensuring affordability and accessibility. Operations are established in key locations like Jaipur and Ahmedabad, serving healthcare needs for conditions such as bronchitis and arthritis. A wide array of treatments is offered to meet evolving demands in the sector, with emphasis on ethical practices and innovative solutions for patients and providers nationwide. This approach has positioned the company at the forefront of pharmaceutical distribution.

Aster Medipharm offers Cardiac and Diabetic Products and Analgesic and Antiulcerants.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available